G. Lyratzopoulos

First name
G.
Last name
Lyratzopoulos
Rafiq, M. ., White, B. ., Barclay, M. ., Abel, G. ., Renzi, C. ., & Lyratzopoulos, G. . (2025). A UK population-based case-control study of blood tests before cancer diagnosis in patients with non-specific abdominal symptoms. Br J Cancer. http://doi.org/10.1038/s41416-024-02936-9
White, B. ., Zakkak, N. ., Renzi, C. ., Rafiq, M. ., Gonzalez-Izquierdo, A. ., Denaxas, S. ., … Barclay, M. E. (2024). Underlying disease risk among patients with fatigue: a population-based cohort study in primary care. Br J Gen Pract, 75, e57–67. http://doi.org/10.3399/bjgp.2025.0093
Whitfield, E. ., White, B. ., Barclay, M. E., Rafiq, M. ., Renzi, C. ., Rous, B. ., … Lyratzopoulos, G. . (2024). Differences in recording of cancer diagnosis between datasets in England: A population-based study of linked cancer registration, hospital, and primary care data. Cancer Epidemiol, 94, 102703. http://doi.org/10.1016/j.canep.2024.102703
Rafiq, M. ., Renzi, C. ., White, B. ., Zakkak, N. ., Nicholson, B. ., Lyratzopoulos, G. ., & Barclay, M. . (2024). Predictive value of abnormal blood tests for detecting cancer in primary care patients with nonspecific abdominal symptoms: A population-based cohort study of 477,870 patients in England. PLoS Med, 21, e1004426. http://doi.org/10.1371/journal.pmed.1004426
White, B. ., Zakkak, N. ., Renzi, C. ., Rafiq, M. ., Gonzalez-Izquierdo, A. ., Denaxas, S. ., … Barclay, M. . (2024). Underlying disease risk among fatigued patients: a population-based cohort study in primary care. Br J Gen Pract. http://doi.org/10.3399/bjgp.2024.0093
Harrison, H. ., Ip, S. ., Renzi, C. ., Li, Y. ., Barclay, M. ., Usher-Smith, J. ., … Antoniou, A. C. (2024). Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort. BMC Med Res Methodol, 24, 71. http://doi.org/10.1186/s12874-024-02175-9
Barclay, M. ., Renzi, C. ., Antoniou, A. ., Denaxas, S. ., Harrison, H. ., Ip, S. ., … Lyratzopoulos, G. . (2023). Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold. PLOS Digit Health, 2, e0000383. http://doi.org/10.1371/journal.pdig.0000383
Wickramasinghe, B. ., Renzi, C. ., Barclay, M. ., Callister, M. E. J., Rafiq, M. ., & Lyratzopoulos, G. . (2023). Pre-diagnostic prescribing patterns in dyspnoea patients with as-yet-undiagnosed lung cancer: A longitudinal study of linked primary care and cancer registry data. Cancer Epidemiol, 86, 102429. http://doi.org/10.1016/j.canep.2023.102429
White, B. ., Renzi, C. ., Barclay, M. ., & Lyratzopoulos, G. . (2023). Underlying cancer risk among patients with fatigue and other vague symptoms: a population-based cohort study in primary care. Br J Gen Pract, 73, e75-e87. http://doi.org/10.3399/bjgp.2022.0371
Rafiq, M. ., Abel, G. ., Renzi, C. ., & Lyratzopoulos, G. . (2022). Steroid prescribing in primary care increases prior to Hodgkin lymphoma diagnosis: A UK nationwide case-control study. Cancer Epidemiol, 81, 102284. http://doi.org/10.1016/j.canep.2022.102284